CD79A and infection: In the late phase of infection (>60 dpso), IgG and IgA antibodies against S1 of SARS‐CoV‐2 were detected in 85.1% and 80.5% of the samples (n = 49), respectively, while IgG and IgM antibodies against NCP were detected in 81.4% and 0%, respectively.